|
1
|
Gerlich WH: Medical virology of hepatitis
B: How it began and where we are now. Virol J.
10:2392013.PubMed/NCBI
|
|
2
|
Teng B, Burant CF and Davidson NO:
Molecular cloning of an apolipoprotein B messenger RNA editing
protein. Science. 260:1816–1819. 1993.PubMed/NCBI
|
|
3
|
Wedekind JE, Dance GS, Sowden MP and Smith
HC: Messenger RNA editing in mammals: New members of the APOBEC
family seeking roles in the family business. Trends Genet.
19:207–216. 2003.PubMed/NCBI
|
|
4
|
Deng Y, Du Y, Zhang Q, Han X and Cao G:
Human cytidine deaminases facilitate hepatitis B virus evolution
and link inflammation and hepatocellular carcinoma. Cancer Lett.
343:161–171. 2014.PubMed/NCBI
|
|
5
|
Nguyen DH, Gummuluru S and Hu J:
Deamination-independent inhibition of hepatitis B virus reverse
transcription by APOBEC3G. J Virol. 81:4465–4472. 2007.PubMed/NCBI
|
|
6
|
Rösler C, Köck J, Kann M, Malim MH, Blum
HE, Baumert TF and von Weizsäcker F: APOBEC-mediated interference
with hepadnavirus production. Hepatology. 42:301–309.
2005.PubMed/NCBI
|
|
7
|
Koning FA, Newman EN, Kim EY, Kunstman KJ,
Wolinsky SM and Malim MH: Defining APOBEC3 expression patterns in
human tissues and hematopoietic cell subsets. J Virol.
83:9474–9485. 2009.PubMed/NCBI
|
|
8
|
Vartanian JP, Henry M, Marchio A, Suspène
R, Aynaud MM, Guétard D, Cervantes-Gonzalez M, Battiston C,
Mazzaferro V, Pineau P, et al: Massive APOBEC3 editing of hepatitis
B viral DNA in cirrhosis. PLoS Pathog. 6:e10009282010.PubMed/NCBI
|
|
9
|
Turelli P, Mangeat B, Jost S, Vianin S and
Trono D: Inhibition of hepatitis B virus replication by APOBEC3G.
Science. 303:18292004.PubMed/NCBI
|
|
10
|
Köck J and Blum HE: Hypermutation of
hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J Gen
Virol. 89:1184–1191. 2008.PubMed/NCBI
|
|
11
|
Henry M, Guétard D, Suspène R, Rusniok C,
Wain-Hobson S and Vartanian JP: Genetic editing of HBV DNA by
monodomain human APOBEC3 cytidine deaminases and the recombinant
nature of APOBEC3G. PLoS One. 4:e42772009.PubMed/NCBI
|
|
12
|
Suspène R, Guétard D, Henry M, Sommer P,
Wain-Hobson S and Vartanian JP: Extensive editing of both hepatitis
B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in
vivo. Proc Natl Acad Sci USA. 102:8321–8326. 2005.PubMed/NCBI
|
|
13
|
Soros VB and Greene WC: APOBEC3G and
HIV-1: Strike and counterstrike. Curr Infect Dis Rep. 8:317–323.
2006.PubMed/NCBI
|
|
14
|
Chiu YL and Greene WC: Multifaceted
antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol.
27:291–297. 2006.PubMed/NCBI
|
|
15
|
Svarovskaia ES, Xu H, Mbisa JL, Barr R,
Gorelick RJ, Ono A, Freed EO, Hu WS and Pathak VK: Human
apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G
(APOBEC3G) is incorporated into HIV-1 virions through interactions
with viral and nonviral RNAs. J Biol Chem. 279:35822–35828.
2004.PubMed/NCBI
|
|
16
|
Bonvin M, Achermann F, Greeve I, Stroka D,
Keogh A, Inderbitzin D, Candinas D, Sommer P, Wain-Hobson S,
Vartanian JP, et al: Interferon-inducible expression of APOBEC3
editing enzymes in human hepatocytes and inhibition of hepatitis B
virus replication. Hepatology. 43:1364–1374. 2006.PubMed/NCBI
|
|
17
|
El-Zayadi AR: Hepatitis B virus infection:
The Egyptian situation. Arab J Gastroenterol. 8:94–98. 2007.
|
|
18
|
Guan R, Yap I, Wong L, Tan LH, Oon CJ and
Wee A: Evidence of viral replication in HBsAg positive patients
with hepatocellular carcinoma: Measurement of serum hepatitis B
virus deoxyribonucleic acid (HBV-DNA). Ann Acad Med Singapore.
18:8–11, 21989. 1989.PubMed/NCBI
|
|
19
|
Zhao D, Wang X, Lou G, Peng G, Li J, Zhu
H, Chen F, Li S, Liu D, Chen Z, et al: APOBEC3G directly binds
Hepatitis B virus core protein in cell and cell free systems. Virus
Res. 151:213–219. 2010.PubMed/NCBI
|
|
20
|
Stenglein MD, Burns MB, Li M, Lengyel J
and Harris RS: APOBEC3 proteins mediate the clearance of foreign
DNA from human cells. Nat Struct Mol Biol. 17:222–229.
2010.PubMed/NCBI
|
|
21
|
Vartanian JP, Henry M, Marchio A, Suspene
R, Aynaud MM, Guetard D, Cervantes-Gonzalez M, Battiston C,
Mazzaferro V, Pineau P, et al: Massive APOBEC3 editing of hepatitis
B viral DNA in cirrhosis. PLoS Pathog. 6:e10009282010.PubMed/NCBI
|
|
22
|
Noguchi C, Hiraga N, Mori N, Tsuge M,
Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, et
al: Dual effect of APOBEC3G on Hepatitis B virus. J Gen Virol.
88:432–440. 2007.PubMed/NCBI
|
|
23
|
Seppen J: Unedited inhibition of HBV
replication by APOBEC3G. J Hepatol. 41:1068–1069. 2004.PubMed/NCBI
|
|
24
|
Tanaka Y, Marusawa H, Seno H, Matsumoto Y,
Ueda Y, Kodama Y, Endo Y, Yamauchi J, Matsumoto T, Takaori-Kondo A,
et al: Anti-viral protein APOBEC3G is induced by interferon-alpha
stimulation in human hepatocytes. Biochem Biophys Res Commun.
341:314–319. 2006.PubMed/NCBI
|
